Endocrinology
|
February 10, 2025

Estrogen Metabolites in Urine: Key Indicators of Hormone Metabolism

Written By
Dr. Emilie Wilson ND, L.Ac.
Medically Reviewed by
Updated On
February 21, 2025

Your body processes and eliminates estrogen through metabolic pathways that influence overall hormonal balance. 

Proper estrogen metabolism is associated with various aspects of health, including bone density and menstrual cycle regulation. Ongoing research explores how differences in estrogen metabolism relate to hormone-related conditions and highlight the usefulness of estrogen metabolite testing.

In this article, we’ll explore how urine estrogen metabolite testing works, why it’s valuable, and how both patients and practitioners can use the results to better understand hormonal health.

[signup]

What is Estrogen?

Estrogen is an important hormone that affects many parts of the body. It works by attaching to estrogen receptors in the body, which send signals to cells to help them function properly. 

Estrogen is a key hormone for women's health, but it also has essential roles for men and overall well-being.

Here's a simple explanation of how it works and what it does:

Reproductive Health

Estrogen is essential for the menstrual cycle and ovulation. It helps the body prepare for pregnancy by thickening the lining of the uterus. It also plays a key role during puberty, helping develop secondary female characteristics like breasts and wider hips.

Bone Health

Estrogen helps keep bones strong by promoting the growth of new bone and preventing bone loss. It protects against osteoporosis, a condition that makes bones weak and more likely to break.

Brain and Nerve Health

Estrogen interacts with brain cells, supporting cognitive function and mood regulation. Some research suggests an association between estrogen levels and memory or neuroprotection.  Estrogen may also be associated with a lower risk of brain diseases like Alzheimer’s, though individual responses vary.

Heart and Blood Vessel Health

Estrogen supports the heart and blood vessels by keeping them healthy and relaxed, reducing the risk of heart disease. It also helps manage cholesterol levels by raising the more protective cholesterol (HDL) and lowering the high-risk cholesterol (LDL).

Metabolism and Fat Control

Estrogen helps the body control fat by reducing belly fat and improving how the body uses insulin. This lowers the chances of developing type 2 diabetes and supports overall metabolic health.

Skin and Hair Health

Estrogen keeps skin soft, hydrated, and elastic while also supporting collagen production. It helps prevent hair thinning, especially before menopause, keeping hair healthy and strong.

Mood and Sleep

Estrogen supports a balanced mood and may help improve sleep. These benefits are especially noticeable during times of hormonal changes, like menopause.

Immune and Body Repair

Estrogen helps lower inflammation and supports a strong immune system. It also aids in tissue repair and keeps skin and blood vessels healthy.

What Is Urine Estrogen Metabolite Testing?

Urine estrogen metabolite testing measures how estrogen is broken down in your body. When estrogen is metabolized, it goes through two major detoxification phases in the liver:

Phase I Detoxification

During phase I metabolism, specific enzymes convert estrogen into molecules called metabolites. Generally speaking:

  • CYP3A4 produces 2-OH and 4-OH estrogen metabolites, as well as the “proliferative” 16-OH-E1 metabolite.

Phase II Detoxification

The liver converts these metabolites to even less harmful chemicals (e.g., by methylation), making it easier for the body to eliminate them through urine.

  • COMT typically converts the phase I estrogen metabolites into their methylated forms. 

How the Test Works

Patients provide a urine sample, generally either samples collected over 24 hours or as dried urine strips.

The test measures levels of different metabolites and their ratios to evaluate the efficiency of estrogen detoxification.

When to Consider This Test

Urine estrogen metabolite testing provides insight into estrogen metabolism and may assist in evaluating detoxification pathways. However, its applicability varies based on individual health conditions and treatment approaches.

Hormonal Imbalance Symptoms

Symptoms like heavy periods, PMS, bloating, mood swings, and low libido may indicate problems with estrogen metabolism. Testing can help uncover underlying imbalances that contribute to these issues.

Cancer Risk Assessment

Certain estrogen metabolites have been studied for their potential role in DNA interactions. Research is ongoing to understand their associations with hormone-sensitive conditions, including breast health.

This test may be helpful for individuals with a family history of estrogen-sensitive cancers.

Detoxification Pathway Function

Estrogen is processed through two detoxification phases in the liver. If these pathways aren’t working efficiently, it can lead to hormonal problems. 

Testing estrogen metabolites may provide insights into liver detoxification function, which is particularly important for patients with hormone imbalance symptoms.

Perimenopause and Menopause

During perimenopause and menopause, hormonal shifts can cause symptoms like hot flashes, night sweats, vaginal dryness, sleep problems, mood swings, and weight gain

Estrogen metabolite testing helps manage these symptoms and guides the use of hormone replacement therapy (HRT); however, it is important to note that urine testing for hormone metabolites is not appropriate for all forms of bioidentical hormone replacement therapy.

Chronic Conditions

Conditions like endometriosis, fibroids, PCOS, and autoimmune diseases may be influenced by estrogen metabolism. Testing can provide insights into estrogen’s role in these conditions and monitor treatment progress.

Weight and Metabolism

Estrogen imbalance can contribute to stubborn abdominal weight gain and other metabolic issues

Testing provides data on estrogen metabolites, which, when considered alongside clinical history and other diagnostic tools, may contribute to a broader understanding of metabolic health.

Bone and Heart Health

Estrogen is essential for maintaining strong bones and a healthy cardiovascular system. Testing can identify metabolite patterns that might increase the risk of osteoporosis or heart disease.

Inflammation and Detox Support

Imbalances in estrogen metabolites can worsen inflammation, which is often seen in conditions like migraines, fibromyalgia, or chronic fatigue syndrome. Testing helps practitioners recommend detoxification strategies to reduce inflammation and symptoms.

Environmental Toxins

Xenoestrogens are chemicals found in plastics, pesticides, and personal care products that can mimic estrogen in the body. This test can shed light on the impact of these toxins on estrogen metabolism.

Genetics

Certain genetic variations, such as those in the COMT, CYP1A1, or CYP1B1 enzymes, can affect how the body processes estrogen. Testing helps uncover whether certain genetic variations may be causing less-than-optimal estrogen metabolism.

Gut Health and Estrogen Metabolism

The gut microbiome, particularly the estrobolome, is key in regulating estrogen levels. Estrogen metabolite testing can identify whether additional testing for gut imbalances, such as dysbiosis, is warranted, especially in patients with digestive symptoms or concerns.

Unexplained Symptoms

For patients with symptoms like migraines, fatigue, acne, or hair loss that don’t have a clear cause, testing estrogen metabolites can uncover hidden imbalances and guide treatment.

Key Estrogen Metabolites to Test

Urine testing looks at specific estrogen metabolites to give a complete picture of estrogen metabolism. The key metabolites are:

2-Hydroxyestrone (2-OH-E1)

2-OH-E1 is considered a “protective” metabolite of estrogen with weak estrogenic activity. It is linked to a lower risk of hormone-related cancers. 

2-Hydroxyestradiol (2-OH-E2)

2-OH-E2, a breakdown product of estradiol, is considered a protective metabolite because it has a weaker effect on estrogen-sensitive tissues, which may reduce the risk of problems like estrogen-driven excessive cell growth. 

2-OH-E2 reflects how efficiently estradiol, the most active estrogen, is detoxified.

4-Hydroxyestrone (4-OH-E1)

4-OH-E1 is a metabolite of estrogen. Although it has weak estrogen effects, it can cause DNA damage and increase the risk of hormone-related cancers, like breast cancer, if the body doesn’t detoxify properly.

4-Hydroxyestradiol (4-OH-E2)

4-OH-E2 is a metabolite of the hormone estradiol. If not properly processed into a safer form (4-methoxyestradiol), it can form harmful substances called quinones that damage DNA, increasing the risk of breast cancer.

16α-Hydroxyestrone (16α-OH-E1)

16α-OH-E1 is an estrogen metabolite with estrogenic effects. It helps support bone health, but high levels can raise the risk of hormone-related cancers like breast cancer.

2-Methoxyestrone (2-MeO-E1)

A neutralized metabolite of 2-OH-E1, 2-MeO-E1 is formed through methylation during phase II metabolism.

High levels suggest effective detoxification and may be linked to a lower risk of certain hormone-related cancers, while low levels may indicate methylation problems.

2-Methoxyestradiol (2-MeO-E2)

2-MeO-E2 is a neutralized metabolite of 2-OH-E2, also formed during phase 2 metabolism. 

2-MeO-E2 may block the growth of new blood vessels that tumors need to grow, causing abnormal cells to die. It may also help lower inflammation and control oxidative stress.

Interpreting Estrogen Metabolites in Urine Testing

Interpreting test results helps identify whether estrogen is being metabolized efficiently. Both individual metabolite levels and their ratios are important. 

It is always important to interpret these findings within the context of a person’s medical history and comprehensive estrogen metabolite panel.

High Levels

  • 4-Hydroxyestrone (4-OH-E1) and/or 4-Hydroxyestradiol (4-OH-E2): elevated levels of these metabolites may suggest a need to optimize hormone levels.
  • 16α-Hydroxyestrone (16α-OH-E1): high levels may indicate estrogen imbalance and can be associated with conditions like estrogen-positive cancers, although results must be interpreted within the context of other clinical data.
  • 2-Hydroxyestrone (2-OH-E1) and/or 2-Hydroxyestradiol (2-OH-E2): while these are generally considered more protective forms of estrogen metabolites, higher levels have been associated with health concerns. Additional insight may be gained by examining metabolite ratios. 

Low Levels

  • 2-Hydroxyestrone (2-OH-E1) and/or 2-Hydroxyestradiol (2-OH-E2): low levels may mean inefficient Phase I detoxification, limiting the production of protective metabolites.

Key Ratios to Understand

  • 2-OH/16-OH E1 Ratio: compares protective (2-OH-E1) to proliferative (16α-OH-E1) metabolites. A low ratio may be associated with an increased risk of hormone-sensitive conditions.
  • 2-OH/4-OH E1 Ratio: compares the protective (2-OH-E1) metabolite to the potentially harmful (4-OH-E1) metabolite. A low ratio may indicate a higher risk for DNA damage and hormone-related cancers.
  • Methylation Ratio: indicates the efficiency of Phase II detoxification by comparing 2-MeO-E1 to its precursor, 2-OH-E1.

Factors Influencing Estrogen Metabolism

Your body’s ability to process estrogen can be affected by several factors:

Genetics

Variations in genes like CYP1A1, CYP1B1, and COMT influence how efficiently estrogen is detoxified.

Liver Health

The liver is the main site for the conversion of estrogen into its metabolites.

Gut Health

A healthy gut microbiome helps eliminate excess estrogen through stool. Consistently imbalanced estrogen metabolites despite reasonable therapies may signal a need for digestive health testing, such as the GI MAP stool test or the GI Effects Comprehensive stool panel

Diet and Lifestyle Factors

  • Sleep: changes in estrogen levels, like during menopause or the days before your period, can make it harder to sleep, and poor sleep can also worsen hormone problems, creating a two-way connection.

Limitations of Estrogen Metabolite Testing

While this test is highly informative, it has some limitations:

  • It measures metabolites, not active hormone levels in blood or tissues.
  • It provides a snapshot, meaning results might not capture fluctuations over time.
  • It is not particularly useful in pregnancy, postpartum, breastfeeding, in children or prepubescent adolescents, or in settings where hormone levels are very different than typical adult hormone levels. 
  • It is not helpful in people with liver or kidney disease or those on certain medications. 

This test is best used in conjunction with other tests, such as saliva and/or blood hormone panels, for a comprehensive hormone assessment.

Optimizing Estrogen Metabolism

Improve estrogen metabolism and reduce risks with these strategies:

Dietary Changes

Supplements

  • Diindolylmethane (DIM): research indicates that DIM may support protective estrogen metabolism.
  • Methylated B vitamins: these support healthy methylation and detoxification.
  • Sulforaphane: this compound, naturally high in broccoli sprouts, supports detox enzymes and healthy estrogen processing.

While some dietary compounds, such as DIM, sulforaphane, and methylated B vitamins, have been studied for their role in estrogen metabolism, always consult a healthcare professional before making changes to supplementation.

Lifestyle Tips

  • Manage Stress: chronic stress may disrupt hormone balance; practice mindfulness or yoga.
  • Prioritize Sleep: quality sleep regulates hormone levels. 
  • Exercise Regularly: exercise improves circulation and detox pathways and reduces fat tissue-related estrogen production.
  • Avoid Xenoestrogens: use glass containers, organic produce, and non-toxic products to reduce exposure to endocrine-disrupting chemicals.

[signup]

Key Takeaways

  • Estrogen metabolism affects overall health: It plays a role in bone strength, mood, metabolism, and cardiovascular health.
  • Urine estrogen metabolite testing measures how the body processes estrogen, providing insight into hormone balance and detoxification.
  • Testing may be useful for evaluating hormone imbalance symptoms, menopause management, metabolic health, and potential risks related to estrogen-sensitive conditions.
  • Key metabolites include 2-OH (protective), 4-OH (potentially harmful), and 16α-OH (proliferative) estrogens. Ratios between these can offer insights into hormone health.
  • Factors affecting metabolism: Genetics, liver function, gut health, diet, and lifestyle all influence estrogen processing.
  • Limitations: This test provides a snapshot of estrogen breakdown but does not measure active hormone levels or replace other hormone testing.
  • Ways to support healthy estrogen metabolism: Eat cruciferous vegetables, get enough fiber, limit processed foods, reduce toxin exposure, manage stress, and consider targeted supplements like DIM, sulforaphane, and methylated B vitamins (under medical guidance).
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

2-Hydroxyestradiol | Rupa Health. (2020). Rupa Health. https://www.rupahealth.com/biomarkers/2-hydroxyestradiol 

4-Hydroxyestrone | Rupa Health. (2020). Rupa Health. https://www.rupahealth.com/biomarkers/2-hydroxyestrone 

4-Hydroxyestradiol | Rupa Health. (2020). Rupa Health. https://www.rupahealth.com/biomarkers/4-hydroxyestradiol 

4-Hydroxyestrone | Rupa Health. (2020). Rupa Health. https://www.rupahealth.com/biomarkers/4-hydroxyestrone 

2-Methoxyestradiol | Rupa Health. (2020). Rupa Health. https://www.rupahealth.com/biomarkers/2-methoxyestradiol 

2-Methoxyestrone | Rupa Health. (2020). Rupa Health. https://www.rupahealth.com/biomarkers/2-methoxyestrone 

16-Hydroxyestrone | Rupa Health. (2020). Rupa Health. https://www.rupahealth.com/biomarkers/16-hydroxyestrone 

Amabebe, E., & Anumba, D. O. C. (2018). Psychosocial Stress, Cortisol Levels, and Maintenance of Vaginal Health. Frontiers in endocrinology, 9, 568. https://doi.org/10.3389/fendo.2018.00568

Baker, J. M., Al-Nakkash, L., & Herbst-Kralovetz, M. M. (2017). Estrogen-gut microbiome axis: Physiological and clinical implications. Maturitas, 103(103), 45–53. https://doi.org/10.1016/j.maturitas.2017.06.025

Bradlow, H. L., Davis, D. L., Lin, G., Sepkovic, D., & Tiwari, R. (1995). Effects of pesticides on the ratio of 16 alpha/2-hydroxyestrone: a biologic marker of breast cancer risk. Environmental health perspectives, 103 Suppl 7(Suppl 7), 147–150. https://doi.org/10.1289/ehp.95103s7147

Breehl L, Caban O. Physiology, Puberty. [Updated 2023 Mar 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534827/

Brown, L. M., & Clegg, D. J. (2010). Central effects of estradiol in the regulation of food intake, body weight, and adiposity. The Journal of steroid biochemistry and molecular biology, 122(1-3), 65–73. https://doi.org/10.1016/j.jsbmb.2009.12.005

Bryant, A. (2024, September 2). How to Have a Good Night Sleep: Top Proven Strategies for Better Rest. Rupa Health. https://www.rupahealth.com/post/how-to-have-a-good-night-sleep-top-proven-strategies-for-better-rest 

Bukato, K., Kostrzewa, T., Gammazza, A. M., Gorska-Ponikowska, M., & Sawicki, S. (2024). Endogenous estrogen metabolites as oxidative stress mediators and endometrial cancer biomarkers. Cell Communication and Signaling : CCS, 22, 205. https://doi.org/10.1186/s12964-024-01583-0

Caldon C. E. (2014). Estrogen signaling and the DNA damage response in hormone dependent breast cancers. Frontiers in oncology, 4, 106. https://doi.org/10.3389/fonc.2014.00106

Chakrabarti, S., Lekontseva, O., & Davidge, S. T. (2008). Estrogen is a modulator of vascular inflammation. IUBMB Life, 60(6), 376–382. https://doi.org/10.1002/iub.48

Chantalat, E., Valera, M. C., Vaysse, C., Noirrit, E., Rusidze, M., Weyl, A., Vergriete, K., Buscail, E., Lluel, P., Fontaine, C., Arnal, J. F., & Lenfant, F. (2020). Estrogen Receptors and Endometriosis. International journal of molecular sciences, 21(8), 2815. https://doi.org/10.3390/ijms21082815

Cloyd, J. A Functional Medicine Approach to Addressing Hair Loss in Women. (2023, September 8). Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-addressing-hair-loss-in-women 

Cloyd, J. High Cholesterol: Causes, Implications, and Effective Management Strategies. (2024, June 28). Rupa Health. https://www.rupahealth.com/post/high-cholesterol-causes-implication 

Conner, V. (2022, September 13). Fibromyalgia: Causes, Symptoms, & Alternative Treatments. Rupa Health. https://www.rupahealth.com/post/fibromyalgia-causes-symptoms-treatments 

Conner, V. (2022, October 11). 6 Complementary and Alternative Therapies for Chronic Fatigue Syndrome. Rupa Health. https://www.rupahealth.com/post/6-natural-therapies-that-can-help-with-chronic-fatigue-symptoms 

Creedon, K. (2022, March 18). 8 Ways To Prevent Osteoporosis As You Age. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-osteoporosis 

Cutolo, M., Capellino, S., Sulli, A., Serioli, B., Secchi, M. E., Villaggio, B., & Straub, R. H. (2006). Estrogens and autoimmune diseases. Annals of the New York Academy of Sciences, 1089, 538–547. https://doi.org/10.1196/annals.1386.043

DeCesaris, L. (2023, January 25). How to Support a Healthy Menstrual Cycle. Rupa Health. https://www.rupahealth.com/post/how-to-support-a-healthy-menstrual-cycle 

DeCesaris, L. (2023, August 16). How To Test For Female Hormones: A Comprehensive Guide. Rupa Health. https://www.rupahealth.com/post/how-to-test-for-female-hormones-a-comprehensive-guide 

Delgado BJ, Lopez-Ojeda W. Estrogen. [Updated 2023 Jun 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538260/

DUTCH Plus by Precision Analytical (DUTCH). (n.d.). Rupa Health. https://www.rupahealth.com/lab-tests/dutch-dutch-plus 

Emond, J. P., Caron, P., Pušić, M., Turcotte, V., Simonyan, D., Vogler, A., Osredkar, J., Rižner, T. L., & Guillemette, C. (2023). Circulating estradiol and its biologically active metabolites in endometriosis and in relation to pain symptoms. Frontiers in endocrinology, 13, 1034614. https://doi.org/10.3389/fendo.2022.1034614

Eliassen, A. H., Missmer, S. A., Tworoger, S. S., & Hankinson, S. E. (2008). Circulating 2-Hydroxy- and 16 -Hydroxy Estrone Levels and Risk of Breast Cancer among Postmenopausal Women. Cancer Epidemiology Biomarkers & Prevention, 17(8), 2029–2035. https://doi.org/10.1158/1055-9965.epi-08-0262

Emmanuelle, N. E., Marie-Cécile, V., Florence, T., Jean-François, A., Françoise, L., Coralie, F., & Alexia, V. (2021). Critical Role of Estrogens on Bone Homeostasis in Both Male and Female: From Physiology to Medical Implications. International journal of molecular sciences, 22(4), 1568. https://doi.org/10.3390/ijms22041568

Falk, R. T., Brinton, L. A., Dorgan, J. F., Fuhrman, B. J., Veenstra, T. D., Xu, X., & Gierach, G. L. (2013). Relationship of serum estrogens and estrogen metabolites to postmenopausal breast cancer risk: a nested case-control study. Breast Cancer Research, 15(2). https://doi.org/10.1186/bcr3416

Farkas, S., Szabó, A., Hegyi, A. E., Török, B., Fazekas, C. L., Ernszt, D., Kovács, T., & Zelena, D. (2022). Estradiol and Estrogen-like Alternative Therapies in Use: The Importance of the Selective and Non-Classical Actions. Biomedicines, 10(4), 861. https://doi.org/10.3390/biomedicines10040861

Fowke, J. H., Longcope, C., & Hebert, J. R. (2000). Brassica vegetable consumption shifts estrogen metabolism in healthy postmenopausal women. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 9(8), 773–779.

Fussell, K. C., Udasin, R. G., Smith, P. J., Gallo, M. A., & Laskin, J. D. (2011). Catechol metabolites of endogenous estrogens induce redox cycling and generate reactive oxygen species in breast epithelial cells. Carcinogenesis, 32(8), 1285–1293. https://doi.org/10.1093/carcin/bgr109

Gava, G., Orsili, I., Alvisi, S., Mancini, I., Seracchioli, R., & Meriggiola, M. C. (2019). Cognition, Mood and Sleep in Menopausal Transition: The Role of Menopause Hormone Therapy. Medicina (Kaunas, Lithuania), 55(10), 668. https://doi.org/10.3390/medicina55100668

GI Effects® Comprehensive Profile - 1 day by Genova Diagnostics. (n.d.). Rupa Health. https://www.rupahealth.com/lab-tests/genova-gi-effects-comprehensive-profile-1-day 

GI-MAP + Zonulin by Diagnostic Solutions. (n.d.). Rupa Health. https://www.rupahealth.com/lab-tests/diagnostic-solutions-gi-map-zonulin 

Gu, C. Y., Qin, X. J., Qu, Y. Y., Zhu, Y., Wan, F. N., Zhang, G. M., Sun, L. J., Zhu, Y., & Ye, D. W. (2016). Genetic variants of the CYP1B1 gene as predictors of biochemical recurrence after radical prostatectomy in localized prostate cancer patients. Medicine, 95(27), e4066. https://doi.org/10.1097/MD.0000000000004066

Guinter, M. A., McLain, A. C., Merchant, A. T., Sandler, D. P., & Steck, S. E. (2018). A dietary pattern based on estrogen metabolism is associated with breast cancer risk in a prospective cohort of postmenopausal women. International journal of cancer, 143(3), 580–590. https://doi.org/10.1002/ijc.31387

Hara, Y., Waters, E. M., McEwen, B. S., & Morrison, J. H. (2015). Estrogen Effects on Cognitive and Synaptic Health Over the Lifecourse. Physiological reviews, 95(3), 785–807. https://doi.org/10.1152/physrev.00036.2014

Hartman, T. J., Sisti, J. S., Hankinson, S. E., Xu, X., Eliassen, A. H., & Ziegler, R. (2016). Alcohol Consumption and Urinary Estrogens and Estrogen Metabolites in Premenopausal Women. Hormones & cancer, 7(1), 65–74. https://doi.org/10.1007/s12672-015-0249-7

Haufe, A., & Leeners, B. (2023). Sleep disturbances across a woman’s lifespan: What is the role of reproductive hormones? Journal of the Endocrine Society, 7(5). https://doi.org/10.1210/jendso/bvad036

Huang, Z., Guengerich, F. P., & Kaminsky, L. S. (1998). 16Alpha-hydroxylation of estrone by human cytochrome P4503A4/5. Carcinogenesis, 19(5), 867–872. https://doi.org/10.1093/carcin/19.5.867

Khakham, C. (2023, May 23). An integrative medicine approach to alzheimer’s disease: Testing, nutrition, and supplements. Rupa Health. https://www.rupahealth.com/post/to-functional-medicine-labs-that-help-individualize-treatment-for-alzheimers-disease 

Khakham, C. (2023, April 6). Understanding Your Risk of Cardiovascular Disease With Functional Medicine Labs. Rupa Health. https://www.rupahealth.com/post/understanding-your-risk-of-cardiovascular-disease-with-functional-medicine-labs 

Knowlton, A. A., & Lee, A. R. (2012). Estrogen and the cardiovascular system. Pharmacology & therapeutics, 135(1), 54–70. https://doi.org/10.1016/j.pharmthera.2012.03.007

Kwa, M., Plottel, C. S., Blaser, M. J., & Adams, S. (2016). The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer. Journal of the National Cancer Institute, 108(8), djw029. https://doi.org/10.1093/jnci/djw029

La Merrill, M. A., Vandenberg, L. N., Smith, M. T., Goodson, W., Browne, P., Patisaul, H. B., Guyton, K. Z., Kortenkamp, A., Cogliano, V. J., Woodruff, T. J., Rieswijk, L., Sone, H., Korach, K. S., Gore, A. C., Zeise, L., & Zoeller, R. T. (2019). Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification. Nature Reviews Endocrinology, 16(1), 45–57. https://doi.org/10.1038/s41574-019-0273-8

Lee, A. J., Cai, M. X., Thomas, P. E., Conney, A. H., & Zhu, B. T. (2003). Characterization of the Oxidative Metabolites of 17β-Estradiol and Estrone Formed by 15 Selectively Expressed Human Cytochrome P450 Isoforms. Endocrinology, 144(8), 3382–3398. https://doi.org/10.1210/en.2003-0192

Lizcano, F., & Guzmán, G. (2014). Estrogen Deficiency and the Origin of Obesity during Menopause. BioMed research international, 2014, 757461. https://doi.org/10.1155/2014/757461

Maholy, N. (2023, April 14). How to reduce stress through mind-body therapies. Rupa Health. https://www.rupahealth.com/post/how-to-reduce-stress-through-mind-body-therapies  

Maskarinec, G., Heak, S., Morimoto, Y., Custer, L., & Franke, A. A. (2012). The relation of urinary estrogen metabolites with mammographic densities in premenopausal women. Cancer Epidemiology, 36(5), e310–e316. https://doi.org/10.1016/j.canep.2012.03.014

Mauras, N., Santen, R. J., Colón-Otero, G., Hossain, J., Wang, Q., Mesaros, C., & Blair, I. A. (2015). Estrogens and Their Genotoxic Metabolites Are Increased in Obese Prepubertal Girls. The Journal of clinical endocrinology and metabolism, 100(6), 2322–2328. https://doi.org/10.1210/jc.2015-1495

Mayo Clinic. (2019). Menopause weight gain: Stop the middle age spread. Mayo Clinic. https://www.mayoclinic.org/healthy-lifestyle/womens-health/in-depth/menopause-weight-gain/art-20046058

Miao, S., Yang, F., Wang, Y., Shao, C., Zava, D. T., Ding, Q., & Shi, Y. E. (2019). 4-Hydroxy estrogen metabolite, causing genomic instability by attenuating the function of spindle-assembly checkpoint, can serve as a biomarker for breast cancer. American journal of translational research, 11(8), 4992–5007.

Napoli, N., Villareal, D. T., Mumm, S., Halstead, L., Sheikh, S., Cagaanan, M., Rini, G. B., & Armamento-Villareal, R. (2005). Effect of CYP1A1 gene polymorphisms on estrogen metabolism and bone density. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 20(2), 232–239. https://doi.org/10.1359/JBMR.041110

Napoli, N., Faccio, R., Shrestha, V., Bucchieri, S., Rini, G. B., & Armamento-Villareal, R. (2007). Estrogen metabolism modulates bone density in men. Calcified tissue international, 80(4), 227–232. https://doi.org/10.1007/s00223-007-9014-4

National Institute of Environmental Health Sciences. (2024, July 22). Endocrine Disruptors. National Institute of Environmental Health Sciences. https://www.niehs.nih.gov/health/topics/agents/endocrine

Nerattini, M., Jett, S., Andy, C., Carlton, C., Zarate, C., Boneu, C., Battista, M. T., Silky Pahlajani, Loeb‐Zeitlin, S., Havryulik, Y., Williams, S., Christos, P. J., Fink, M. E., Roberta Dı́az Brinton, & Mosconi, L. (2023). Systematic review and meta-analysis of the effects of menopause hormone therapy on risk of Alzheimer’s disease and dementia. Frontiers in Aging Neuroscience, 15. https://doi.org/10.3389/fnagi.2023.1260427

Parada-Bustamante, A., Valencia, C., Reuquen, P., Diaz, P., Rincion-Rodriguez, R., & Orihuela, P. (2015). Role of 2-methoxyestradiol, an Endogenous Estrogen Metabolite, in Health and Disease. Mini-Reviews in Medicinal Chemistry, 15(5), 427–438. https://doi.org/10.2174/1389557515666150226121052

Reed BG, Carr BR. The Normal Menstrual Cycle and the Control of Ovulation. [Updated 2018 Aug 5]. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279054/

Samavat, H., & Kurzer, M. S. (2015). Estrogen metabolism and breast cancer. Cancer letters, 356(2 Pt A), 231–243. https://doi.org/10.1016/j.canlet.2014.04.018

Santoro N. (2016). Perimenopause: From Research to Practice. Journal of women's health (2002), 25(4), 332–339. https://doi.org/10.1089/jwh.2015.5556

Sepkovic, D. W., & Bradlow, H. L. (2009). Estrogen hydroxylation--the good and the bad. Annals of the New York Academy of Sciences, 1155, 57–67. https://doi.org/10.1111/j.1749-6632.2008.03675.x

Stevenson, S., & Thornton, J. (2007). Effect of estrogens on skin aging and the potential role of SERMs. Clinical interventions in aging, 2(3), 283–297. https://doi.org/10.2147/cia.s798

Straub, R. H. (2007). The Complex Role of Estrogens in Inflammation. Endocrine Reviews, 28(5), 521–574. https://doi.org/10.1210/er.2007-0001

Swaneck, G. E., & Fishman, J. (1988). Covalent binding of the endogenous estrogen 16 alpha-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization. Proceedings of the National Academy of Sciences of the United States of America, 85(21), 7831–7835. https://doi.org/10.1073/pnas.85.21.7831

Sweetnich, J. (2023, April 25). Complementary and Integrative Medicine Approaches to Type 2 Diabetes Management. Rupa Health. https://www.rupahealth.com/post/complementary-and-integrative-medicine-approaches-to-type-2-diabetes-management 

Sweetnich, J. Functional Medicine Labs That Help Monitor Bioidentical Hormone Replacement Therapy. (2023, February 24). Rupa Health. https://www.rupahealth.com/post/functional-medicine-labs-that-help-monitor-bioidentical-hormone-replacement-therapy 

Sweetnich, J. (2023, February 15). How to Support Optimal Liver Estrogen Detoxification. Rupa Health. https://www.rupahealth.com/post/how-the-liver-affects-female-hormones 

Sweetnich, J. (2023, January 19). Integrative Medicine Treatments for Migraines Sufferers. Rupa Health. https://www.rupahealth.com/post/integrative-medicine-treatments-for-migraines

Thomson, C., Chow, S., Roe, D., Wertheim, B., Chalasani, P., Altbach, M., Thompson, P., Stopek, A., & Maskaranic, G. (2017). Effect of Diindolylmethane on Estrogen-related Hormones, Metabolites and Tamoxifen Metabolism: Results of a Randomized, Placebo-controlled Trial. Cancer Epidemiology Biomarkers & Prevention, 26(3), 435.1-435. https://doi.org/10.1158/1055-9965.epi-17-0027

Tsuchiya, Y., Nakajima, M., Kyo, S., Kanaya, T., Inoue, M., & Yokoi, T. (2004). Human CYP1B1 is regulated by estradiol via estrogen receptor. Cancer research, 64(9), 3119–3125. https://doi.org/10.1158/0008-5472.can-04-0166

Vigil, P., Meléndez, J., Petkovic, G., & Del Río, J. P. (2022). The importance of estradiol for body weight regulation in women. Frontiers in endocrinology, 13, 951186. https://doi.org/10.3389/fendo.2022.951186

Wang, X., Ha, D., Yoshitake, R., Chan, Y. S., Sadava, D., & Chen, S. (2021). Exploring the Biological Activity and Mechanism of Xenoestrogens and Phytoestrogens in Cancers: Emerging Methods and Concepts. International journal of molecular sciences, 22(16), 8798. https://doi.org/10.3390/ijms22168798

Weinberg, J. (2022, March 31). How to tell if you have an estrogen imbalance. Www.rupahealth.com. https://www.rupahealth.com/post/a-functional-medicine-approach-to-estrogen-imbalance 

Wong, J. Y., Gold, E. B., Johnson, W. O., & Lee, J. S. (2016). Circulating Sex Hormones and Risk of Uterine Fibroids: Study of Women's Health Across the Nation (SWAN). The Journal of clinical endocrinology and metabolism, 101(1), 123–130. https://doi.org/10.1210/jc.2015-2935

World Health Organization. (2024, October 16). Menopause. World Health Organisation. https://www.who.int/news-room/fact-sheets/detail/menopause

Xu, S., Sun, J., Zhang, Y., Ji, J., & Sun, X. (2021). Opposite estrogen effects of estrone and 2-hydroxyestrone on MCF-7 sensitivity to the cytotoxic action of cell growth, oxidative stress and inflammation activity. Ecotoxicology and Environmental Safety, 209, 111754. https://doi.org/10.1016/j.ecoenv.2020.111754

Xu, X. L., Deng, S. L., Lian, Z. X., & Yu, K. (2021). Estrogen Receptors in Polycystic Ovary Syndrome. Cells, 10(2), 459. https://doi.org/10.3390/cells10020459

Yager J. D. (2012). Catechol-O-methyltransferase: characteristics, polymorphisms and role in breast cancer. Drug discovery today. Disease mechanisms, 9(1-2), e41–e46. https://doi.org/10.1016/j.ddmec.2012.10.002

Yoshimura, H. (2023, October 10). A Root Cause Medicine Approach to Chronic Inflammation. Rupa Health. https://www.rupahealth.com/post/a-root-cause-medicine-approach-to-chronic-inflammation 

Yue, W., et al. Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis. (2003). The Journal of Steroid Biochemistry and Molecular Biology, 86(3-5), 477–486. https://doi.org/10.1016/S0960-0760(03)00377-7

Zengul, A. G., Demark-Wahnefried, W., Barnes, S., Morrow, C. D., Bertrand, B., Berryhill, T. F., & Frugé, A. D. (2021). Associations between Dietary Fiber, the Fecal Microbiota and Estrogen Metabolism in Postmenopausal Women with Breast Cancer. Nutrition and cancer, 73(7), 1108–1117. https://doi.org/10.1080/01635581.2020.1784444

Zhu B. T. (2003). Medical hypothesis: hyperhomocysteinemia is a risk factor for estrogen-induced hormonal cancer. International journal of oncology, 22(3), 499–508.

Ziegler, R. G., Fuhrman, B. J., Moore, S. C., & Matthews, C. E. (2015). Epidemiologic studies of estrogen metabolism and breast cancer. Steroids, 99(Pt A), 67–75. https://doi.org/10.1016/j.steroids.2015.02.015

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Endocrinology
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.